OptiNose Inc reports results for the quarter ended in June - Earnings Summary

OptiNose

08/08/2024 15:22

* OptiNose Inc  OPTN.OQ  reported a quarterly adjusted loss
of 5
cents​​ per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of 2
cents.  The mean expectation of four analysts for the quarter
was for a loss of 8 cents per share. Wall Street expected
results to range from -8 cents to -7 cents per share.
    * Revenue rose 5.3% to $20.49 million from a year ago;
analysts
expected $20.58 million. 
    * OptiNose Inc's reported EPS for the quarter was a loss
of 5
cents​.
    * The company reported a quarterly loss of $7.58 million.
    * OptiNose Inc shares had risen by 1.0% this quarter and
lost 18.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for OptiNose Inc is
$3.00 
This summary was machine generated from LSEG data August 8 at
02:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.08          -0.05          Beat
 Mar. 31 2024      -0.11          -0.12          Missed
 Dec. 31 2023      -0.09          -0.09          Met
 Sep. 30 2023      -0.09          -0.08          Beat